Latest News about XLRN
Recent news which mentions XLRN
   3 Dow Stocks to Take Seriously in 2023
   
  
  
  November 29, 2022
  From InvestorPlace
 
   Is Merck Stock a Buy?
   
  
  
  November 20, 2021
  From Motley Fool
 
   Merck Is a Dividend Play Ready to Get Back in Gear
   
  
  
  November 16, 2021
  From InvestorPlace
 
   Is Merck's Planned Acquisition of Acceleron in Trouble?
   
  
  
  November 12, 2021
  From Motley Fool
 
   The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
   
  
  
  November 09, 2021
  From Benzinga
 
   3 Dow Stocks That Are Screaming Buys in November
   
  
  
  November 09, 2021
  From Motley Fool
 
   3 Best Biotech Stocks to Buy in November
   
  
  
  November 08, 2021
  From Motley Fool
 
   Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
   
  
  
  November 06, 2021
  From Motley Fool
 
   Merck Pushes Acceleron Buyout By Refiling For Antitrust Review
   
  
  
  November 01, 2021
  From Benzinga
 From Motley Fool
 
   2 Biotech Stocks That Could Go Parabolic This Week
   
  
  
  October 24, 2021
  From Motley Fool
 
   Bristol Myers Pledges To Offload Acceleron Shares: Bloomberg
   
  
  
  October 21, 2021
  From Benzinga
 
   2 Best Biotech Stocks to Buy Right Now
   
  
  
  October 18, 2021
  From Motley Fool
 
   2 Top Healthcare Stocks That Could Be Bought Out in 2022
   
  
  
  October 16, 2021
  From Motley Fool
 
   Better COVID-19 Stock: Merck or Pfizer?
   
  
  
  October 16, 2021
  From Motley Fool
 
   3 Top Warren Buffett Stocks to Buy in October
   
  
  
  October 10, 2021
  From Motley Fool
 
   3 Reasons to Buy Merck Stock Right Now
   
  
  
  October 09, 2021
  From Motley Fool
 
   Is an Acquisition of Acceleron a Smart Move for Merck?
   
  
  
  October 08, 2021
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
   
  
  
  October 07, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2021
   
  
  
  October 04, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
   
  
  
  October 03, 2021
  From Benzinga
 
   Activist Investor Thinks Merck Undervalues Acceleron Buy
   
  
  
  October 01, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021
   
  
  
  October 01, 2021
  From Benzinga
 
   10 Biggest Price Target Changes For Friday
   
  
  
  October 01, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
   
  
  
  September 30, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.